Results 141 to 150 of about 34,916 (281)

Implementation and use of risk minimization control tools in the EU: A multistakeholder survey

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study characterized stakeholders' experiences with national implementation of risk minimization control tools (RMCTs), such as healthcare professional qualification, healthcare facility accreditation and medical intervention prior to treatment initiation, for eight medicinal products across eight European Union countries. Methods We conducted
Sharon C. M. Essink   +21 more
wiley   +1 more source

Plasmon Tunability of Gold Nanostars at the Tip Apexes

open access: yesACS Omega, 2018
Nicolas Pazos-Perez   +2 more
doaj   +1 more source

New therapeutic options for metabolic‐associated steatotic liver disease

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
An increasing number of patients are being diagnosed with metabolic dysfunction‐associated steatotic liver disease (MASLD). MASLD results from disturbances in hepatic lipid metabolism and is associated with an increased risk of cirrhosis and hepatocellular carcinoma and significant extrahepatic morbidity, including cardiovascular disease and ...
Tessa Straatmijer, Midas Mulder
wiley   +1 more source

Paediatric clonidine medication errors: Findings from a multicentre French study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to describe the characteristics of medication errors involving clonidine in paediatric patients and reported to French Network of Pharmacovigilance and Poison Control Centres. Methods This retrospective observational study analysed clonidine‐related medication errors reported between 1985 and June 2024 in patients under 12 years ...
Eve‐Marie Thillard   +8 more
wiley   +1 more source

Clinical relevance of pharmacogenomic information for improving prescribing practices in acutely admitted older medical patients

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Safe prescribing and effective medication review during acute hospitalization depends on accurate information about liver and kidney function because these organs are responsible for the elimination of most medications. While estimates for kidney function are widely used, comparable markers of hepatic drug‐metabolizing capacity are not routinely ...
Louise Westberg Strejby Christensen   +17 more
wiley   +1 more source

KRITIK PENETAPAN HARGA IJARAH PADA GADAI EMAS (TINJAUAN FIKIH DAN ETIKA)

open access: yesJurnal Hukum Islam, 2013
Pembiayaan gadai emas di bank syariah mencuat ketika harga emas dunia mengalami fluktuasi yang cukup tajam. Hal ini mendorong masyarakat beralih kepada investasi emas.
Rinda Asytuti
doaj  

The EMAS Archiving Program [PDF]

open access: yesThe Computer Journal, 1975
openaire   +1 more source

EMA – Publication of the EMA’s Annual activity report for 2024

open access: yes
The consolidated Annual activity report provides an overview of the activities and achievements of the European Medicines Agency (hereinafter EMA or the Agency) in 2024. The EMA Annual activity report 2024 is a report of the EMA Executive Director. It is a key component of the strategic planning and programming cycle and the basis upon which the EMA ...
openaire   +1 more source

Cefepime exposure in prolonged or intermittent infusion in critically ill children

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Cefepime is commonly used in critically ill children for whom there is a high between‐subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, prolonged infusion of beta‐lactams seems to be the most efficient.
Marc Hobeika   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy